Coupling interferon to a synthetic PEG molecule could increase the therapeutic’s dosing schedule from every other day to every one to two weeks, according to researchers who believe the technology has blockbuster potential.
France-based Flamel Technologies and Merck Serono have shook hands
on a new €2m ($2.9m) deal which would see Flamel's Medusa
technology used to develop an extended-release profile of an
undisclosed therapeutic protein.
Applied Biosystems has announced the availability of the first
laboratory system that uses mass spectrometry to perform amino acid
analysis, greatly improving the effectiveness and reliability of
the data obtained.
Biopharmaceutical firm Oragenics has received funding from a US
government agency for a technology which promises cost-effective
production of commercially important bioactive peptides with
Surface modification firm SurModics has acquired Intralytix's
polyester-amide (PEA) biodegradable polymers, boosting the
company's capacity for specific drug delivery, a capability in high
demand by its customers.
Chemical company BASF has developed a process for the production of
new chiral intermediates for the pharmaceutical industry on a
commercial scale, further raising the product efficiency of drugs
and reducing undesirable effects.
Innovative laboratory technology that produces a sharper picture of
the nano-machine that translates genetic program into proteins
gives a unique insight into how some types of antibiotics work
leading to the design of better ones.
Akzo Nobel business unit Diosynth, which specialises in the
production of complex active biopharmaceutical ingredients for the
pharmaceutical sector, has won a contract to apply its new method
for manufacturing synthetic peptides...
Sigma, a division of Sigma-Aldrich Corporation has launched a new
offering of Custom AQUA Peptides for use with Protein-AQUA
Quantitative Proteomics, enabling important applications as
differential protein expression, biomarker quantification...
Setting aside the acrimony of a patent dispute, UK separations
company Whatman is to buy German rival Schleicher & Schuell for
€50.2 million, allowing it to narrow the gap between itself and the
main players Pall and Millipore.
US drug delivery company SCOLR Pharma, announced it has filed a
provisional patent application utilizing the company's patented
amino acid technology for the Controlled Delivery Technology (CDT)
extended release form of ondansetron.
Germany's BASF has entered into a collaboration with Solvias of
Switzerland that will see the two companies combine their expertise
in the development and manufacture of chiral intermediates for the
life science industry.
Swiss contract manufacturing company Lonza has licensed a
technology that makes it possible to make peptide drugs that are
longer and have a more complex structure than is possible using
conventional techniques, reports Phil Taylor.
A new technique for engineering protein crystals is helping
scientistsfigure out the three-dimensional structures of some
important biological molecules, including a key plague protein
whose structure has eluded researchers until...
German chemistry specialist ChiroBlock has pulled out of the
business of producing and marketing chiral compounds and will focus
exclusively on providing chiral research and synthesis services for
pharmaceutical and biotechnology...
Germany's third-largest chemicals company Degussa has won the Frost
& Sullivan Product of the Year Award for its L-hydantoinase
enzymatic process for single-step production of L-amino acids, used
in the pharmaceutical, food...